Cart
sales@molnova.com
4-O-Methylochnaflavone
CAS No. 49619-87-6
4-O-Methylochnaflavone( ——— )
Catalog No. M38942 CAS No. 49619-87-6
4'-O-Methylochnaflavone is a biflavonoid isolated from Lonicera japonica, suppresses mouse lymphocyte proliferation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 208 | In Stock |
|
| 10MG | 358 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-O-Methylochnaflavone
-
NoteResearch use only, not for human use.
-
Brief Description4'-O-Methylochnaflavone is a biflavonoid isolated from Lonicera japonica, suppresses mouse lymphocyte proliferation.
-
Description4'-O-Methylochnaflavone is a natural product
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number49619-87-6
-
Formula Weight552.48
-
Molecular FormulaC31H20O10
-
Purity>98% (HPLC)
-
SolubilityDMSO : < 1 mg/mL (insoluble or slightly soluble) H2O : < 0.1 mg/mL (insoluble)
-
SMILESO=C1C=C(OC=2C=C(O)C=C(O)C12)C=3C=CC(OC=4C=C(C=CC4OC)C=5OC=6C=C(O)C=C(O)C6C(=O)C5)=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lee SJ, et al. Suppression of mouse lymphocyte proliferation in vitro by naturally-occurring biflavonoids. Life Sci. 1995;57(6):551-8.?
molnova catalog
related products
-
3-Mercaptopropionic ...
3-Mercaptopropionic acid (3-Sulfanylpropanoic acid) is an intermediate in the metabolism of organosulfur in the natural environment and is commonly used in nanoparticles.
-
Ly93
Ly93 is a selective and orally active sphingomyelin synthase 2 (SMS2) inhibitor (IC50: 91 nM) used for studying atherosclerosis.
-
PhosTAC7
PhosTAC7 successfully induced ternary protein complex formation and dephosphorylation of phosphatidylserine 318 (pS318) by Halo-FOXO3a in a dose-dependent manner.
